Teprotumumab is effective for TED but carries risk of serious side effects
- Posted on: Mar 22 2022
- Leave a response
Teprotumumab has proven efficacy in patients with thyroid eye disease (TED) and potential in treating compressive optic neuropathy, but adverse events have been noted.
Source: AAO
Posted in: Uncategorized
